{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:20Z","timestamp":1793900480576,"version":"4.8.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1800801"],"award-info":[{"award-number":["2023YFA1800801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022419","name":"National Institute for Health Research Southampton Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203319"],"award-info":[{"award-number":["NIHR203319"]}],"id":[{"id":"10.13039\/501100022419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070588"],"award-info":[{"award-number":["82070588"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370577"],"award-info":[{"award-number":["82370577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.medj.2026.101099","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:05:12Z","timestamp":1776186312000},"page":"101099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities"],"prefix":"10.1016","volume":"7","author":[{"given":"Xiao-Dong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-Yue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fudi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daolin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-2631","authenticated-orcid":false,"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101099_bib1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib2","first-page":"1990","article-title":"Global burden of metabolic diseases","volume":"160","author":"Zhang","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.medj.2026.101099_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102848","article-title":"Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021","volume":"76","author":"Zhou","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.medj.2026.101099_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib5","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jhep.2024.03.039","article-title":"Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both","volume":"81","author":"Zhou","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.medj.2026.101099_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","article-title":"An international multidisciplinary consensus statement on MAFLD and the risk of CVD","volume":"17","author":"Zhou","year":"2023","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.medj.2026.101099_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2026.101099_bib10","first-page":"S1043","article-title":"Mechanisms and therapeutic insights into MASH-associated fibrosis","volume":"26","author":"Zhu","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.medj.2026.101099_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.medj.2026.101099_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105088","article-title":"Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation","volume":"102","author":"Peleman","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.medj.2026.101099_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.molmed.2025.08.006","article-title":"MAFLD: a ferroptotic disease","volume":"32","author":"Cui","year":"2026","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.medj.2026.101099_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(13)70174-8","article-title":"Effects of iron overload on chronic metabolic diseases","volume":"2","author":"Fern\u00e1ndez-Real","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.medj.2026.101099_bib15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41418-024-01348-9","article-title":"Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Peleman","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.medj.2026.101099_bib16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.cmet.2024.07.013","article-title":"Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH","volume":"36","author":"Tao","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The Metabolic Underpinnings of Ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2021.03.014","article-title":"Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD","volume":"75","author":"Corradini","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cmet.2024.05.008","article-title":"Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157450","article-title":"Arachidonic acid induces ferroptosis in hepatocellular carcinoma via the SIRT5-ACSL4\/LPCAT3\/ALOX15 axis, leading to lipid peroxidation and mitochondrial dysfunction","volume":"148","author":"Xue","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.medj.2026.101099_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202300379","article-title":"Ferroptosis Detection: From Approaches to Applications","volume":"62","author":"Zeng","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.medj.2026.101099_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2023.02.012","article-title":"FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner","volume":"55","author":"Bi","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.medj.2026.101099_bib23","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.apsb.2022.02.003","article-title":"Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease","volume":"12","author":"Tong","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.medj.2026.101099_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.medj.2026.101099_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.medj.2026.101099_bib26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.medj.2026.101099_bib27","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/liv.15163","article-title":"Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?","volume":"42","author":"Feng","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.medj.2026.101099_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1286449","article-title":"Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.medj.2026.101099_bib29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101099_bib30","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","article-title":"DAMPs in the immunogenicity of cell death","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.medj.2026.101099_bib31","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s44318-024-00055-y","article-title":"NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis","volume":"43","author":"Ramos","year":"2024","journal-title":"Embo j"},{"key":"10.1016\/j.medj.2026.101099_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.medj.2026.101099_bib33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","article-title":"A guideline on the molecular ecosystem regulating ferroptosis","volume":"26","author":"Dai","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.medj.2026.101099_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101099_bib35","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.medj.2026.101099_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.celrep.2015.12.065","article-title":"NCOA4 Deficiency Impairs Systemic Iron Homeostasis","volume":"14","author":"Bellelli","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2026.101099_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108560","article-title":"Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD","volume":"26","author":"Yue","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.medj.2026.101099_bib38","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.medj.2026.101099_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.medj.2026.101099_bib40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/HEP.0000000000000375","article-title":"Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis","volume":"79","author":"Tian","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","article-title":"Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State","volume":"26","author":"Magtanong","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.medj.2026.101099_bib42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101099_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.freeradbiomed.2017.01.023","article-title":"Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis","volume":"111","author":"Bellanti","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.medj.2026.101099_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111586","article-title":"Tamoxifen regulates ferroptosis of hepatocytes by targeting SLC1A5 to activate hepatic stellate cells and liver fibrosis","volume":"418","author":"Shi","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.medj.2026.101099_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101099_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib47","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbrc.2018.12.039","article-title":"Lipid storage and lipophagy regulates ferroptosis","volume":"508","author":"Bai","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.medj.2026.101099_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2025.126395","article-title":"Novel insights into DBP-induced zebrafish liver inflammatory damage: Ferroptosis activating the HMGB1-TLR4-NF-\u03baB signaling pathway","volume":"376","author":"Li","year":"2025","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.medj.2026.101099_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118903","article-title":"Toll-like receptor 4-mediated inflammatory stimulation in Kupffer cell enhances arsenite-induced liver fibrosis by triggering hepatic stellate cell activation","volume":"303","author":"Song","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.medj.2026.101099_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.ade4335","article-title":"The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation","volume":"17","author":"Fernandez-Rojo","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.medj.2026.101099_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92839-z","article-title":"Decreased ferroportin in hepatocytes promotes macrophages polarize towards an M2-like phenotype and liver fibrosis","volume":"11","author":"Cai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2026.101099_bib52","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib53","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","article-title":"PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8(+) T cell ferroptosis","volume":"57","author":"Ping","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.medj.2026.101099_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cytogfr.2025.06.007","article-title":"Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy","volume":"84","author":"Gao","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.medj.2026.101099_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.medj.2026.101099_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: Death by Lipid Peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.medj.2026.101099_bib57","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","article-title":"GPX4-independent ferroptosis-a new strategy in disease's therapy","volume":"8","author":"Ma","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.medj.2026.101099_bib58","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","article-title":"Regulation of ferroptosis by lipid metabolism","volume":"33","author":"Pope","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.medj.2026.101099_bib59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.medj.2026.101099_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/ars.2023.0278","article-title":"Dynamic Regulation of Ferroptosis by Lipid Metabolism","volume":"39","author":"Naowarojna","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.medj.2026.101099_bib61","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.23712","article-title":"Hepatic iron loading in mice increases cholesterol biosynthesis","volume":"52","author":"Graham","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12944-024-02129-6","article-title":"Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study","volume":"23","author":"Song","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.medj.2026.101099_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066570","article-title":"High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats","volume":"8","author":"Meli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2026.101099_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: The role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.medj.2026.101099_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2025.137166","article-title":"Bisphenol S accelerates the progression of high fat diet-induced NAFLD by triggering ferroptosis via regulating HMGCS2","volume":"487","author":"Xie","year":"2025","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.medj.2026.101099_bib66","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","article-title":"Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.102032","article-title":"Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH","volume":"24","author":"Kanamori","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.medj.2026.101099_bib69","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000684","article-title":"The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD","volume":"9","author":"Angendohr","year":"2025","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.medj.2026.101099_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopha.2018.06.060","article-title":"Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway","volume":"106","author":"Sui","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.medj.2026.101099_bib71","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/hepr.70032","article-title":"Fibulin Family Members: New Players in Liver Fibrosis and Potential Biomarkers in Chronic Liver Diseases","volume":"55","author":"Bouezzedine","year":"2025","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.medj.2026.101099_bib72","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib73","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: a product and mediator of oxidative stress","volume":"42","author":"Uchida","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.medj.2026.101099_bib74","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.7150\/thno.106597","article-title":"Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.medj.2026.101099_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13030352","article-title":"Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications","volume":"13","author":"Wu","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.medj.2026.101099_bib76","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.25711","article-title":"Hepatic activation of IKK\/NF\u03baB signaling induces liver fibrosis via macrophage-mediated chronic inflammation","volume":"56","author":"Sunami","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib77","doi-asserted-by":"crossref","first-page":"539","DOI":"10.14218\/JCTH.2023.00562","article-title":"Mitochondrial GRIM19 Loss Induces Liver Fibrosis through NLRP3\/IL33 Activation via Reactive Oxygen Species\/NF-\u043aB Signaling","volume":"12","author":"Xu","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib78","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s11010-022-04369-5","article-title":"TGF-\u03b2 activates NLRP3 inflammasome by an autocrine production of TGF-\u03b2 in LX-2 human hepatic stellate cells","volume":"477","author":"Kang","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.medj.2026.101099_bib79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00535-023-01996-7","article-title":"Mitochondrial stress induces hepatic stellate cell activation in response to the ATF4\/TRIB3 pathway stimulation","volume":"58","author":"Ye","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.medj.2026.101099_bib80","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.2147\/JIR.S427868","article-title":"Programmed Cell Death in Liver Fibrosis","volume":"16","author":"Gao","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.medj.2026.101099_bib81","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2018.07.006","article-title":"The role of iron in hepatic inflammation and hepatocellular carcinoma","volume":"133","author":"Miyanishi","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.medj.2026.101099_bib82","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/HEP.0000000000000390","article-title":"Ferroptosis in hepatocellular carcinoma: from bench to bedside","volume":"80","author":"Tang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib83","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy","volume":"128","author":"Ajoolabady","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.medj.2026.101099_bib84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12072-023-10593-y","article-title":"Targeting ferroptosis in hepatocellular carcinoma","volume":"18","author":"Mo","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.medj.2026.101099_bib85","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28574","article-title":"Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis","volume":"64","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib86","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2025.08.035","article-title":"FATP5 deficiency alleviates MASH via remodeling hepatic lipid composition to suppress ferroptosis","volume":"240","author":"Liu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.medj.2026.101099_bib87","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00109-025-02599-w","article-title":"Involvement of ferroptosis in metabolic dysfunction-associated steatohepatitis-related liver diseases","volume":"103","author":"Liu","year":"2025","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.medj.2026.101099_bib88","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41569-025-01199-y","article-title":"Cardiovascular-kidney-metabolic syndrome and MASLD: integrating medical perspectives","volume":"22","author":"Zhou","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.medj.2026.101099_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156575","article-title":"Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region","volume":"179","author":"Zhang","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.medj.2026.101099_bib90","article-title":"MASLD as a Systemic Metabolic Disease: Expanding the Scope of Cardiovascular-Kidney-Metabolic (CKM) Syndrome","author":"Zhou","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.medj.2026.101099_bib91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.medj.2026.101099_bib92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41575-025-01144-x","article-title":"Heart-liver co-management in MASLD: from concept to clinical practice","volume":"23","author":"Zhou","year":"2026","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(25)00323-1","article-title":"Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: Heart-Liver Co-Management","author":"Zhou","year":"2026","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.medj.2026.101099_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105466","article-title":"Ferroptosis and its emerging roles in cardiovascular diseases","volume":"166","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.medj.2026.101099_bib96","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.medj.2026.101099_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110400","article-title":"HSPB1 suppresses oxLDL-induced vascular smooth muscle cell ferroptosis by inhibiting DPP4","volume":"768","author":"Li","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.medj.2026.101099_bib98","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1002\/mco2.520","article-title":"Antiferroptosis therapy alleviated the development of atherosclerosis","author":"Yang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.medj.2026.101099_bib99","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302116","article-title":"Improving lysosomal ferroptosis with NMN administration protects against heart failure","volume":"6","author":"Yagi","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.medj.2026.101099_bib100","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1093\/eurheartj\/ehaf374","article-title":"Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications","volume":"46","author":"Zhao","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2026.101099_bib101","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41418-022-01110-z","article-title":"Adaptor protein HIP-55-mediated signalosome protects against ferroptosis in myocardial infarction","volume":"30","author":"Jiang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.medj.2026.101099_bib102","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.devcel.2024.12.011","article-title":"HMOX1-LDHB interaction promotes ferroptosis by inducing mitochondrial dysfunction in foamy macrophages during advanced atherosclerosis","volume":"60","author":"Peng","year":"2025","journal-title":"Dev. Cell"},{"key":"10.1016\/j.medj.2026.101099_bib103","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.125.075220","article-title":"ALDH2\/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury","volume":"153","author":"Chen","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2026.101099_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103154","article-title":"Angiotension II directly bind P2X7 receptor to induce myocardial ferroptosis and remodeling by activating human antigen R","volume":"72","author":"Zhong","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.medj.2026.101099_bib105","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf083","article-title":"GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis","volume":"27","author":"Li","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.medj.2026.101099_bib106","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10495-023-01814-8","article-title":"Inhibition of ferroptosis by icariin treatment attenuates excessive ethanol consumption-induced atrial remodeling and susceptibility to atrial fibrillation, role of SIRT1","volume":"28","author":"Yu","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.medj.2026.101099_bib107","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.7150\/thno.54113","article-title":"Ferroptosis as a novel therapeutic target for cardiovascular disease","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.medj.2026.101099_bib108","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.medj.2026.101099_bib109","article-title":"Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD","author":"Zhou","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102201","article-title":"Ferroptosis: Mechanisms and role in diabetes mellitus and its complications","volume":"94","author":"Liu","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.medj.2026.101099_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2019.121390","article-title":"Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway","volume":"384","author":"Wei","year":"2020","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.medj.2026.101099_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.157819","article-title":"Cadmium induces ferroptosis mediated inflammation by activating Gpx4\/Ager\/p65 axis in pancreatic \u03b2-cells","volume":"849","author":"Hong","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.medj.2026.101099_bib113","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41419-018-0506-0","article-title":"Ferroptosis-inducing agents compromise in vitro human islet viability and function","volume":"9","author":"Bruni","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.medj.2026.101099_bib114","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cmet.2025.01.029","article-title":"Ferroptosis in adipose tissue: A promising pathway for treating obesity?","volume":"37","author":"Speakman","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cmet.2024.11.010","article-title":"Adipocyte-derived ferroptotic signaling mitigates obesity","volume":"37","author":"Wang","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib116","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy-stress-mediated AMPK activation inhibits ferroptosis","volume":"22","author":"Lee","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.medj.2026.101099_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166114","article-title":"The central role of glutathione peroxidase 4 in the regulation of ferroptosis and its implications for pro-inflammatory cytokine-mediated beta-cell death","volume":"1867","author":"Kr\u00fcmmel","year":"2021","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.medj.2026.101099_bib118","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.7150\/thno.107367","article-title":"Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2\/GCLC signaling pathway","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.medj.2026.101099_bib119","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S2468-1253(25)00188-8","article-title":"Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis","volume":"10","author":"Celsa","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.medj.2026.101099_bib121","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.medj.2026.101099_bib122","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-025-09710-8","article-title":"Targeting FSP1 triggers ferroptosis in lung cancer","volume":"649","author":"Wu","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101099_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13020208","article-title":"Iron, Oxidative Stress, and Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"13","author":"Gensluckner","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.medj.2026.101099_bib124","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","article-title":"Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity","volume":"566","author":"Vriens","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101099_bib125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","article-title":"Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis","volume":"416","author":"Chang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.medj.2026.101099_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202513655","article-title":"HSP70 Interactome-Mediated Proteolysis Targeting Chimera (HSP70-PROTAC) for Ferroptosis-Driven Cancer Treatment","volume":"13","author":"Dong","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.medj.2026.101099_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70349","article-title":"Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.medj.2026.101099_bib128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/gutjnl-2023-330815","article-title":"Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease","volume":"73","author":"Armandi","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.medj.2026.101099_bib129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3350\/cmh.2024.0782","article-title":"Bioactive metabolites: A clue to the link between MASLD and CKD?","volume":"31","author":"Chen","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S2468-1253(24)00320-0","article-title":"The liver-brain axis in metabolic dysfunction-associated steatotic liver disease","volume":"10","author":"Mikkelsen","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib131","doi-asserted-by":"crossref","DOI":"10.34133\/research.0934","article-title":"Epigenetic Regulation of Ferroptosis in Chronic Kidney Disease: Mechanisms and Implications","volume":"8","author":"Mao","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.medj.2026.101099_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-025-01587-4","article-title":"AARS1-mediated lactylation of H3K18 and STAT1 promotes ferroptosis in diabetic nephropathy","author":"Hong","year":"2026","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.medj.2026.101099_bib133","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2017.7115","article-title":"GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues","volume":"29","author":"Maiorino","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.medj.2026.101099_bib134","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tins.2025.06.008","article-title":"Triggering ferroptosis in neurodegenerative diseases","volume":"48","author":"Nguyen","year":"2025","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.medj.2026.101099_bib135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/ars.2017.7063","article-title":"Mitochondrial Ferritin Is a Hypoxia-Inducible Factor 1\u03b1-Inducible Gene That Protects from Hypoxia-Induced Cell Death in Brain","volume":"30","author":"Wu","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.medj.2026.101099_bib136","first-page":"2504","article-title":"Excitotoxicity, Oxytosis\/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms","volume":"16","author":"Khan","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.medj.2026.101099_bib137","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s43587-025-00907-0","article-title":"Senescent macrophages induce ferroptosis in skeletal muscle and accelerate osteoarthritis-related muscle atrophy","volume":"5","author":"Xiang","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.medj.2026.101099_bib138","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/s41467-023-41832-3","article-title":"Metabolic crosstalk between skeletal muscle cells and liver through IRF4-FSTL1 in nonalcoholic steatohepatitis","volume":"14","author":"Guo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2026.101099_bib139","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41413-024-00398-6","article-title":"Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects","volume":"13","author":"Ru","year":"2025","journal-title":"Bone Res."},{"key":"10.1016\/j.medj.2026.101099_bib140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1433857","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"Sandireddy","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.medj.2026.101099_bib142","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jhep.2025.08.017","article-title":"Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD","volume":"84","author":"Zhou","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.medj.2026.101099_bib143","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001645","article-title":"Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD","author":"Zhou","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.medj.2026.101099_bib144","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cmet.2024.04.020","article-title":"Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periosti","volume":"36","author":"Xie","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.medj.2026.101099_bib145","article-title":"Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.medj.2026.101099_bib146","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.kint.2023.03.012","article-title":"A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease","volume":"104","author":"Olivari","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.medj.2026.101099_bib147","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.chembiol.2020.03.014","article-title":"Achieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis","volume":"27","author":"Bay\u0131r","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.medj.2026.101099_bib148","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","article-title":"Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo","volume":"4","author":"Murphy","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.medj.2026.101099_bib149","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101099_bib150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.freeradbiomed.2016.12.009","article-title":"Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases","volume":"111","author":"Zarkovic","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.medj.2026.101099_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101470","article-title":"Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity","volume":"298","author":"Valentine","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.medj.2026.101099_bib152","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.medj.2026.101099_bib153","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107189119","article-title":"FAF1 blocks ferroptosis by inhibiting peroxidation of polyunsaturated fatty acids","volume":"119","author":"Cui","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101099_bib154","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.medj.2026.101099_bib155","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/j.molcel.2023.09.025","article-title":"Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases","volume":"83","author":"Cui","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.medj.2026.101099_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12020408","article-title":"Mitochondrial Peroxiredoxin 3 Is Rapidly Oxidized and Hyperoxidized by Fatty Acid Hydroperoxides","volume":"12","author":"Cardozo","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.medj.2026.101099_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12010009","article-title":"Mitochondrial Peroxiredoxin III Protects against Non-Alcoholic Fatty Liver Disease Caused by a Methionine-Choline Deficient Diet","volume":"12","author":"Park","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.medj.2026.101099_bib158","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1016\/j.molcel.2024.11.001","article-title":"5H7c: A rabbit monoclonal antibody detecting ferroptotic cells","volume":"84","author":"Cui","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.medj.2026.101099_bib159","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1080\/15548627.2021.2008692","article-title":"DCN released from ferroptotic cells ignites AGER-dependent immune responses","volume":"18","author":"Liu","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.medj.2026.101099_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103858","article-title":"Monitoring ferroptosis in vivo: Iron-driven volatile oxidized lipids as breath biomarkers","volume":"86","author":"Matsuoka","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.medj.2026.101099_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.medj.2026.101099_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174351","article-title":"Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4","volume":"908","author":"Zhu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.medj.2026.101099_bib163","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4103\/1673-5374.293157","article-title":"Liproxstatin-1 is an effective inhibitor of oligodendrocyte ferroptosis induced by inhibition of glutathione peroxidase 4","volume":"16","author":"Fan","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.medj.2026.101099_bib164","article-title":"Targeting Mitochondrial ROS-Mediated Ferroptosis by Quercetin Alleviates High-Fat Diet-Induced Hepatic Lipotoxicity","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.medj.2026.101099_bib165","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1530\/EC-18-0054","article-title":"Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob\/ob mice","volume":"7","author":"Yan","year":"2018","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.medj.2026.101099_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113363","article-title":"Iron chelator deferasirox inhibits NF-\u03baB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths","volume":"153","author":"Jomen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.medj.2026.101099_bib167","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2217\/nnm-2020-0038","article-title":"Combating iron overload: a case for deferoxamine-based nanochelators","volume":"15","author":"Jones","year":"2020","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.medj.2026.101099_bib168","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jconrel.2022.08.056","article-title":"Active transport nanochelators for the reduction of liver iron burden in iron overload","volume":"350","author":"Abbina","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.medj.2026.101099_bib169","doi-asserted-by":"crossref","first-page":"E767","DOI":"10.1152\/ajpendo.00260.2023","article-title":"Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?","volume":"326","author":"Shen","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.medj.2026.101099_bib170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13020-025-01121-1","article-title":"The gut microbiota-mediated ferroptosis pathway: a key mechanism of ginsenoside Rd against metabolism-associated fatty liver disease","volume":"20","author":"Liu","year":"2025","journal-title":"Chin. Med."},{"key":"10.1016\/j.medj.2026.101099_bib171","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/s41467-025-57616-w","article-title":"Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction","volume":"16","author":"Du","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2026.101099_bib172","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/a-2435-2091","article-title":"Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"45","author":"Barber\u00e1","year":"2025","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.medj.2026.101099_bib173","doi-asserted-by":"crossref","DOI":"10.3390\/ph18050650","article-title":"A Comparative Study of N-Acetyl Cysteine, Rosuvastatin, and Vitamin E in the Management of Patients with Non-Alcoholic Steatohepatitis: A Randomized Controlled Trial","volume":"18","author":"Zakaria","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.medj.2026.101099_bib174","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:43:58Z","timestamp":1781279038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":174,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666634026001029"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101099","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101099"}}